1261287-15-3

Upstream product

• 2759-28-6 1-phenylmethylpiperazine 
• 156-38-7 4-hydroxyphenylacetate 

Downstream Products

• 1261287-28-8 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl propylcarbamate 
• 1261287-36-8 1-(4-benzylpiperazin-1-yl)-2-(4-hydroxyphenyl)-ethanone hydrochloride 
• 1261287-31-3 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl o-tolylcarbamate 
• 1261287-29-9 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl ethylcarbamate 
• 1261287-27-7 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl butylcarbamate 
• 1261287-30-2 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl dimethylcarbamate 
• 1228530-90-2 4-(2-(4-benzylpiperazin-1-yl)-2-oxoethyl)-phenyl isopropylcarbamate 

Relevant academic research and scientific papers

Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity

Cancer is a multifactorial disease that may be tackled by targeting different signaling pathways. Heme oxygenase-1 (HO-1) and sigma receptors (σRs) are both overexpressed in different human cancers, including prostate and brain, contributing to the cancer

Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors

The study presents synthesis and biological activity of novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties designed as cholinesterases inhibitors. These fragments turned out to determine compounds' selectivi